4.5 Article

Population pharmacokinetics of roxadustat in Japanese dialysis-dependent chronic kidney disease patients with anaemia

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

Pharmacokinetics of Roxadustat: A Population Analysis of 2855 Dialysis- and Non-Dialysis-Dependent Patients with Chronic Kidney Disease

Dinko Rekic et al.

Summary: A population pharmacokinetic analysis was conducted for Roxadustat, with no significant changes in drug exposure found under the influence of intrinsic and extrinsic factors.

CLINICAL PHARMACOKINETICS (2021)

Article Pharmacology & Pharmacy

Effect of the Phosphate Binders Sevelamer Carbonate and Calcium Acetate on the Pharmacokinetics of Roxadustat After Concomitant or Time-separated Administration in Healthy Individuals

Dorien Groenendaal-van de Meent et al.

Summary: This study investigated the impact of two phosphate binders on the pharmacokinetic properties of roxadustat and found that concomitant administration of phosphate binders significantly reduced the plasma concentration of roxadustat. However, this effect was attenuated when there was a time lag between the administration of roxadustat and phosphate binders.

CLINICAL THERAPEUTICS (2021)

Article Pharmacology & Pharmacy

Effect of Kidney Function and Dialysis on the Pharmacokinetics and Pharmacodynamics of Roxadustat, an Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor

Dorien Groenendaal-van de Meent et al.

Summary: Roxadustat, an orally active hypoxia-inducible factor prolyl hydroxylase inhibitor, was investigated for its pharmacokinetics, metabolic profile, and pharmacodynamics in subjects with different degrees of kidney function. The study found that kidney function impairment increased the AUC of roxadustat and its metabolites, but C-max and t(1/2) were comparable among different groups. Roxadustat and its metabolites were not cleared by hemodialysis/hemodiafiltration (HD/HDF).

EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2021)

Article Medicine, General & Internal

Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis

N. Chen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Urology & Nephrology

Hypoxia-Inducible Factor Activators in Renal Anemia: Current Clinical Experience

Neil S. Sanghani et al.

ADVANCES IN CHRONIC KIDNEY DISEASE (2019)

Article Pharmacology & Pharmacy

Evaluation of the effect of lanthanum carbonate hydrate on the pharmacokinetics of roxadustat in non-elderly healthy adult male subjects

T. Shibata et al.

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2018)

Article Urology & Nephrology

Renal association clinical practice guideline on Anaemia of Chronic Kidney Disease

Ashraf Mikhail et al.

BMC NEPHROLOGY (2017)

Review Medicine, Research & Experimental

A New Approach to the Management of Anemia in CKD Patients: A Review on Roxadustat

Kimberly Becker et al.

ADVANCES IN THERAPY (2017)

Article Hematology

Serum Phosphate and Calcium Should Be Primarily and Consistently Controlled in Prevalent Hemodialysis Patients

Masatomo Taniguchi et al.

THERAPEUTIC APHERESIS AND DIALYSIS (2013)

Article Urology & Nephrology

Chapter 1: Definition and classification of CKD

Kidney International Supplements (2012)

Review Medicine, General & Internal

Drug Therapy: Oral Phosphate Binders in Patients with Kidney Failure.

Marcello Tonelli et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Pharmacology & Pharmacy

Importance of Shrinkage in Empirical Bayes Estimates for Diagnostics: Problems and Solutions

Radojka M. Savic et al.

AAPS JOURNAL (2009)

Article Peripheral Vascular Disease

Chronic Kidney Disease Japan Cohort (CKD-JAC) study: Design and methods

Enyu Imai et al.

HYPERTENSION RESEARCH (2008)

Article Pharmacology & Pharmacy

Derivation of various NONMEM estimation methods

Yaning Wang

JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2007)